Cargando…

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients

AIMS: Risk stratification models of sudden cardiac death (SCD) are based on the assumption that risk factors of SCD affect risk to a similar extent in both sexes. The aim of the study is to evaluate differences in clinical outcomes between sexes and evaluate whether risk factors associated with appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Lingen, Anne‐Lotte C.J., Theuns, Dominic A.M.J., Rijnierse, Mischa T., Becker, Marthe A.J., van de Ven, Peter M., van Rossum, Albert C., van Halm, Vokko P., Kemme, Michiel J.B., Yap, Sing C., Allaart, Cornelis P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497372/ https://www.ncbi.nlm.nih.gov/pubmed/34184828 http://dx.doi.org/10.1002/ehf2.13444

Ejemplares similares

Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE‐CMR
por: van der Lingen, Anne‐Lotte C. J., et al.
Publicado: (2021)

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator
por: Hopman, Luuk H. G. A., et al.
Publicado: (2023)

The role of implantable cardioverter-defibrillators in New York Heart Class I heart failure patients: do not abandon the asymptomatic just yet
por: van der Lingen, Anne-Lotte C J, et al.
Publicado: (2020)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
por: Yap, Sing-Chien, et al.
Publicado: (2015)

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
por: von Gunten, Simon, et al.
Publicado: (2016)

Principles and techniques of imaging in identifying the substrate of ventricular arrhythmia
por: Rijnierse, Mischa T., et al.
Publicado: (2015)

The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review
por: Stoevelaar, Rik, et al.
Publicado: (2018)

Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
por: Stoevelaar, Rik, et al.
Publicado: (2020)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Feasibility of CMR Imaging during Biventricular Pacing: Comparison with Invasive Measurement as a Pathway towards a Novel Optimization Strategy
por: Hopman, Luuk H. G. A., et al.
Publicado: (2023)

Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives
por: Stoevelaar, Rik, et al.
Publicado: (2021)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

Characteristics and prognostic value of right ventricular (dys)function in patients with non‐ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging
por: Becker, Marthe A.J., et al.
Publicado: (2021)

Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records
por: Stoevelaar, Rik, et al.
Publicado: (2019)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life
por: Pedersen, Susanne S, et al.
Publicado: (2009)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis
por: Theuns, Dominic A.M.J., et al.
Publicado: (2010)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot
por: Opić, Petra, et al.
Publicado: (2012)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study
por: Ghossein, M A, et al.
Publicado: (2022)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach
por: Thijssen, Joep, et al.
Publicado: (2011)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Short‐Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators
por: Smoczyńska, Agnieszka, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology
por: Theuns, D. A., et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_577jb8lpkvke84k3ivv3uac0tg